Clinical Trial Update: Long-term Safety Extension to Study TRCA-301 [Phase 3]

View source ↗

Summary

A long-term safety extension for TRCA-301 in metabolic acidosis completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Acidosis

Drugs mentioned

• TRCA-301 (null)

Snippet

Sponsor: Tricida, Inc. | Conditions: Metabolic Acidosis | Phase 3 | Status: COMPLETED | Results posted: 2021-10-22